Directly observed therapy for tuberculosis in New York City: Factors associated with refusal

International Journal of Tuberculosis and Lung Disease

Volumn 8, Issue 4, 2004, Pages 480-485

  Gupta, S ^a   Berg, Debra ^b   De Lott, F ^b   Kellner, P ^b   Driver, C ^b  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

Directly observed therapy; New York City; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; FEMALE; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HOSPITAL ADMISSION; HUMAN; ILLNESS BEHAVIOR; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTICENTER STUDY; OUTPATIENT CARE; PATIENT EDUCATION; PRIORITY JOURNAL; REGISTER; RETROSPECTIVE STUDY; SELF MEDICATION; SHORT COURSE THERAPY; TUBERCULOSIS; UNITED STATES; WORK SCHEDULE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; DIRECTLY OBSERVED THERAPY; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; NEW YORK CITY; PATIENT ADMISSION; RETROSPECTIVE STUDIES; TREATMENT REFUSAL; TUBERCULOSIS;

EID: 2442604701     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Centers for Disease Control and Prevention. Initial therapy for tuberculosis in an era of multidrug-resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR 1993; 42: 1-8.
2. China Tuberculosis Control Collaboration. Results of directly observed short-course chemotherapy in 112,842 Chinese patients with smear-positive tuberculosis. Lancet 1996; 347: 358-362.
3. Frieden T R, Fujiwara P I, Washko R M, Hamburg M A. Tuberculosis in New York City turning the tide. N Engl J Med 1995; 333: 229-233.
4. Chaulk C P, Moore-Rice K, Rizzo R, Chaisson R E. Eleven years of community-based directly observed therapy for tuberculosis. JAMA 1995; 274: 945-951.
5. Weis S E, Slocum P C, Blais F X, et al. The effect of directly observed therapy on the rates of drug-resistance and relapse in tuberculosis. N Engl J Med 1994; 330: 1179-1184.
6. Chaulk C P, Pope D S. The Baltimore city health department program of directly observed therapy for tuberculosis. Clin Chest Med 1997; 18: 149-154.
7. Schecter G F. Supervised therapy in San Francisco. Clin Chest Med 1997; 18: 165-168.
8. Fujiwara P I, Larkin C, Frieden T R. Directly observed therapy in New York City: history, implementation, results, and challenges. Clin Chest Med 1997; 18: 135-148.
9. Schluger N, Ciotoli C, Cohen D, Johnson H, Rom W N. Comprehensive tuberculosis control for patients at high risk for noncompliance. Am J Respir Crit Care Med 1995; 151: 1486-1490.
10. el-Sadr W, Medard F, Barthaud V. Directly observed therapy for tuberculosis: the Harlem Hospital experience, 1993. Am J Public Health 1996; 86: 1146-1149.
11. Boulanger C, Carpenter R, Zabala J. Hospital-based case management and directly observed therapy programs reduce readmission rates for tuberculosis. Vancouver, Canada: XIth International Conference on AIDS 1996; 11: 167 (abstract Mo.C.1655).
12. Salomon N, Perlman D C, Rubenstein A, Mandelman D, McKinley F W, Yancovitz S R. Implementation of universal directly observed therapy at a New York City hospital and evaluation of an out-patient directly observed therapy program. Int J Tuberc Lung Dis 1997; 1: 397-404.
13. New York City Department of Health. Tuberculosis in New York City, 1997: information summary. New York, NY: New York City Department of Health, 1998.
14. Centers for Disease Control and Prevention. Case definitions for infectious disease conditions under public health surveillance. MMWR 1997; 46: 40-41.
15. Essential components of a tuberculosis prevention and control program. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR 1995; 44: 1-16.
16. World Health Organization. Tuberculosis notification update, December 1993: Tuberculosis program, WHO/Geneva. Geneva, Switzerland: WHO, 1994.
17. Dean A G, Dean J A, Coulombier D, et al. Epi Info, Version 6.04c: a word processing, database, and statistics program for epidemiology on microcomputers. Atlanta, GA: Centers for Disease Control and Prevention, 1994.
18. SAS Institute Inc. SAS/STAT Software: Syntax Version 6. Cary, NC: SAS Institute Inc., 1993.
19. Bayer R, Stayton C, Desvarieux M, Healton C, Landesman S, Tsay W Y. Directly observed therapy and treatment completion for tuberculosis in the United States: is universal supervised therapy necessary? Am J Public Health 1998; 88: 1052-1058.
20. Walley J D, Khan M A, Newel J N, Khan M H. Effectiveness of the direct observation component of DOTS for tuberculosis: a randomized controlled trial in Pakistan. Lancet 2001; 357: 664-669.
21. Zwarenstein M, Schoeman J H, Vundule C, Lombard C J, Tatley M. Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis. Lancet 1998; 352: 1340-1343.
22. Kamolratanakul P, Sawert H, Lertmaharit S, et al. Randomized controlled trial of directly observed treatment (DOT) for patients with pulmonary tuberculosis in Thailand. Trans Roy Soc Trop Med Hygiene 1999; 93: 552-557.
23. Chaulk C P, Kazandijian V A. Directly observed therapy for treatment completion of pulmonary tuberculosis. Consensus statement of the Public Health Tuberculosis Guidelines panel. JAMA 1998; 279: 943-948.